Entera Bio (ENTX) Other Non Operating Income (2019 - 2021)
Entera Bio (ENTX) posted quarterly Other Non Operating Income of -$37000.0 for Q2 2021, down 27.59% year-on-year from -$51095.2 in Q2 2020, and down 27.59% on a QoQ basis from -$29000.0 in Q2 2020.
Entera Bio (ENTX) Other Non Operating Income (2019 - 2021) Analysis & Trends
Entera Bio (ENTX) has reported Other Non Operating Income for 3 consecutive years, with -$37000.0 the latest figure, recorded in Q2 2021.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,621.14 Bn | 66,620.85 Bn | - |
| 2 | Nanobiotix | 1,915.18 Bn | 1,915.11 Bn | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - |
| 4 | BeOne Medicines | 471.27 Bn | 466.48 Bn | 1.35 Bn |
| 5 | Vertex Pharmaceuticals | 121.81 Bn | 114.57 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 69.58 Bn | 60.82 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.72 Bn | 62.72 Bn | - |
| 8 | Argenx Se | 55.51 Bn | 50.33 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.35 Bn | 37.35 Bn | - |
| 10 | Entera Bio | 186.78 Mn | 182.64 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2021 | -37,000.00 |
| Jun 30, 2020 | -29,000.00 |
| Jun 30, 2019 | -19,000.00 |